Atenolol
Brand names: ATENIDONE (in combination) TENORETIC (in combination) TENORMIN
Therapeutic Indications
Atenolol is indicated for:
Hypertension
Irrespective of gender only Adults (18 years old or older)
Atenolol is indicated in the treatment of management of hypertension.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Oral - 50-100 mg once daily
Angina pectoris
Irrespective of gender only Adults (18 years old or older)
Atenolol is indicated in the treatment of management of angina pectoris.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Oral - 100 mg given orally once daily
Treatment 2: Oral - 50 mg given twice daily
Myocardial infarction
Irrespective of gender only Adults (18 years old or older)
Atenolol is indicated for the management of myocardial infarction for early intervention in the acute phase.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Oral - 50-100 mg once daily
Treatment 2: Intravenous - 5-10 mg once daily
Cardiac arrhythmias
Irrespective of gender only Adults (18 years old or older)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Oral - 50-100 mg once daily
Treatment 2: Intravenous - 2.5-10mg
Treatment 3: Intravenous - 0,15mg/kg
Contraindications
Active ingredient Atenolol is contraindicated in the following cases:
Second, third-degree heart block
No gender/age discrimination
Uncontrolled heart failure
No gender/age discrimination
Untreated phaeochromocytoma
No gender/age discrimination
Sick sinus syndrome
No gender/age discrimination
Hypotension
No gender/age discrimination
Bradycardia (<45 bpm)
No gender/age discrimination
Metabolic acidosis
No gender/age discrimination
Cardiogenic shock
No gender/age discrimination